An early stage med-tech company, Armonica Technologies is structured around developing its proprietary long-read DNA sequencing technology for precision medicine applications. Currently, standard genome sequencing approaches require extensive library preparation and create a massive computational and bioinformatics problem related to re-assembling the data set. Armonicas technology uses proprietary nanochannels to deliver single DNA molecules through nanopores for optical readout by Raman spectroscopy. The firm's approach will lead to faster, more thorough, and more accurate genomic analysis than is currently available, without the need for library preparation.
